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[7]. The union of ligand binding and catalytic functionsAptamers Meet Allostery
through rational design strategies has proven to be mod-
erately successful. Such judicious integration of func-
tional domains typically relies on a phenomenon of RNA-
ligand interaction termed adaptive binding [2], in which
Engineered RNAs have demonstrated remarkable prop- ligand binding stabilizes local RNA structure. By replac-
erties of molecular recognition and allosteric function. ing a critical element of a catalyst’s secondary structure
Liu and colleagues now report the isolation and in vivo with an aptamer domain, ligand-induced structural sta-
function of a ligand-dependent RNA-based transcrip- bilization and ribozyme activation has been demon-
tion factor that opens wide the door for allosterically strated [8]. However, this design strategy can be signifi-
controllable aptamers. cantly augmented with combinatorial strategies, in
which nucleotide positions in the region conjoining func-
tional domains are randomized, and individuals are se-RNA is a highly versatile biopolymer capable of exhib-
lected on the basis of optimal allosteric performanceiting fundamental biochemical properties once believed
[9]. In this manner, allosteric nucleic acid catalysts thatto be unique to the realm of protein factors and enzymes.
are either activated or inhibited by ligand binding haveThe numerous and varied activities that cellular RNAs
been isolated.fulfill as catalysts or regulators of biological processes
have shattered the view of RNA as a simple biological
intermediary. Moreover, engineered RNAs have served
to further expand the repertoire of biochemical capabili-
ties ascribable to RNA and have offered unique insights
to RNA’s inherent potential for catalysis [1], molecular
recognition and discrimination [2], and allosteric func-
tion [3]. Such engineering efforts are made possible by
RNA’s unique tractability to both rational design and
combinatorial selection techniques [1], the latter of
which is facilitated by the dualistic character of RNA as
an informational and functional molecule. RNA is thus
regarded as an attractive biopolymer for tailoring novel
molecular therapeutic agents and biotechnological
tools.
In this issue of Chemistry & Biology, Liu and col-
leagues report the successful exploitation of RNA’s
molecular recognition and allosteric capabilities in the
creation of an RNA-based transcriptional activator that
is facilely modulated by an effector compound in yeast
[4]. The transcriptional activator functionality is deriva-
tive of a previously isolated RNA aptamer that binds
an unidentified host factor and activates reporter gene
Figure 1. Allosteric Aptamers
expression when localized to the promoter region of
(A) TMR-dependent transcriptional activator isolated by Liu andDNA [5]. By integrating a second RNA aptamer domain
coworkers [4]. An RNA aptamer that functions as a transcriptional
that binds tetramethylrosamine (TMR) [6], Liu and co- activation domain (AD) in yeast by binding an unidentified host factor
workers sought to modulate the function of the adjacent is integrated with the TMR aptamer in such a manner that TMR
binding promotes formation and function of the activation domain.transcriptional activator through conformational changes
The RNA is localized to the promoter of a reporter gene throughin aptamer structure arising from TMR interaction, and
the respective RNA and DNA binding activities of an MS2 coathave succeeded in generating the first biologically active
protein (MS2 CP)-LexA fusion protein.allosteric aptamer (Figure 1A).
(B) General scheme for allosteric aptamer function. Integration of
Such integration of functional RNA domains has pre- effector and target aptamer domains as interdependent or mutually
viously been achieved in the generation of allosteric exclusive functional domains might achieve effector activation or
inhibition of target aptamer function, respectively.RNA catalysts by joining aptamer and ribozyme domains
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Equipped with knowledge regarding the structural with wholly engineered species and brought to bear on
cellular processes [13, 14].features and requirements of both the TMR aptamer
and the RNA-based transcriptional activator, Liu and Importantly, the work presented by Liu and coworkers
suggests a general scheme for developing allostericallycoworkers applied the principles of allosteric nucleic
acid design and selection to isolate TMR-dependent controllable aptamers. In principle, allosteric aptamer
function has previously been observed for a DNA ap-transcriptional activators from a relatively small combi-
natorial library in which a segment linking the aptamer tamer that exhibits mutually exclusive binding of small
molecule ligands between coupled domains [15] anddomains was randomized. TMR-dependent transcrip-
tional activators were isolated based on their ability to by an allosteric ribozyme that exhibits cooperativity in
ligand binding between coupled RNA aptamer domainsactivate HIS3 expression in yeast and confer TMR-
dependent growth in the absence of histidine. The strin- [16]. However, the present work demonstrates more
adaptable methodology for integrating two aptamer do-gency of the selection was aided using 3-aminotriazole
(3-AT), an inhibitor of HIS3 activity, to isolate the most mains and isolating either interdependent or mutually
exclusive aptamer operations (Figure 1B). In this man-potent TMR-dependent transcriptional activators. Of
four isolates obtained, the most potent transcriptional ner, either effector activation or inhibition of target ap-
tamer function might be used to modulate target mole-activator confers absolute TMR-dependent growth in
the absence of histidine and presence of 3-AT. -galac- cule activity. Overlaying such allosteric regulation upon
aptamers that inhibit target protein function could pro-tosidase assays demonstrate that the same isolate pro-
vides a 10-fold TMR-dependent increase in expression vide controllable therapeutic agents that are either acti-
vated or inactivated at will or fine-tuned to achieve aand functions in a dose-dependent manner, thereby es-
tablishing the general function of the TMR-dependent desired outcome. More practically, such allosteric ap-
tamers could be useful biotechnological tools for dis-transcriptional activator as an artificial genetic regula-
tory switch. Sequence analysis of the isolates obtained secting intracellular protein function.
reveals a general strategy for TMR-dependent function
in which the region joining aptamer domains consists Garrett A. Soukup
of a weakened stem element that is likely stabilized by Department of Biomedical Sciences
TMR binding to form the active structure of the adjacent Creighton University School of Medicine
transcriptional activator. Mutational analyses validate 2500 California Plaza
both TMR-dependent function and mechanism, as point Omaha, Nebraska, 68178
mutations designed to obviate TMR binding indeed dis-
rupt transcriptional activation altogether, while a point Selected Reading
mutation that stabilizes the conjoining segment pro-
1. Wilson, D.S., and Szostak, J.W. (1999). Annu. Rev. Biochem.motes TMR-independent transcriptional activation.
68, 611–647.Liu and colleagues’ accomplishment adds a layer of
2. Hermann, T., and Patel, D.J. (2000). Science 287, 820–825.
sophistication upon previous efforts that have applied 3. Silverman, S.K. (2003). RNA 9, 377–383.
aptamers toward genetic regulation. Such efforts have 4. Buskirk, A.R., Landrigan, A., and Liu, D.R. (2004). Chem. Biol.
achieved ligand-dependent inhibition of gene expres- 11, this issue, 1157–1163.
5. Buskirk, A.R., Kehayova, P.D., Landrigan, A., and Liu, D.R.sion by incorporating aptamers within the 5 untrans-
(2003). Chem. Biol. 10, 533–540.lated regions (UTRs) of eukaryotic mRNAs, where ligand
6. Baugh, C., Grate, D., and Wilson, C. (2000). J. Mol. Biol. 301,binding interferes with translation initiation [10, 11]. The
117–128.present work, however, provides a trans-mechanism of
7. Soukup, G.A., and Breaker, R.R. (2000). Curr. Opin. Struct. Biol.
transcriptional control rather than cis-mechanism of 10, 318–325.
post-transcriptional regulation; a feature that might be 8. Soukup, G.A., and Breaker, R.R. (1999). Structure Fold. Des. 7,
more generally applicable toward modulating target 783–791.
9. Soukup, G.A., and Breaker, R.R. (1999). Proc. Natl. Acad. Sci.gene expression, given that such ligand-dependent
USA 96, 3584–3589.transcriptional activators can be localized to specific
10. Werstuck, G., and Green, M.R. (1998). Science 282, 296–298.promoters. Additionally, the present work parallels re-
11. Grate, D., and Wilson, C. (2001). Bioorg. Med. Chem. 9, 2565–
cently discovered mechanisms of natural genetic regu- 2570.
lation by riboswitches [12]. These naturally occurring 12. Mandal, M., and Breaker, R.R. (2004). Nat. Rev. Mol. Cell Biol.
metabolite binding aptamers generally reside in the 5, 451–463.
13. Thompson, K.M., Syrett, H.A., Knudsen, S.M., and Ellington,5-UTRs of prokaryotic mRNAs and regulate gene ex-
A.D. (2002). BMC Biotechnol. 2, 21.pression through metabolite-induced conformational
14. Suess, B., Fink, B., Berens, C., Stentz, R., and Hillen, W. (2004).changes in RNA structure that affect transcriptional ter-
Nucleic Acids Res. 32, 1610–1614.mination or translation initiation. The work of Liu and
15. Wu, L., and Curran, J.F. (1999). Nucleic Acids Res. 27, 1512–
colleagues represents a significant contribution to the 1516.
limited number of demonstrations that similarly refined 16. Jose, A.M., Soukup, G.A., and Breaker, R.R. (2001). Nucleic
Acids Res. 29, 1631–1637.mechanisms of RNA allostery can both be achieved
